 Jonathan Myers
Concepts (520)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biodiversity | 19 | 2022 | 35 | 7.840 |
Why?
| | Trees | 17 | 2022 | 21 | 5.930 |
Why?
| | Laparoscopy | 26 | 2020 | 190 | 5.420 |
Why?
| | Exercise Test | 22 | 2021 | 123 | 4.690 |
Why?
| | Ecosystem | 16 | 2022 | 25 | 4.610 |
Why?
| | General Surgery | 13 | 2020 | 61 | 4.360 |
Why?
| | Gastroplasty | 11 | 2014 | 28 | 3.530 |
Why?
| | Obesity, Morbid | 9 | 2014 | 82 | 2.670 |
Why?
| | Exercise | 11 | 2022 | 454 | 2.650 |
Why?
| | Models, Biological | 12 | 2021 | 428 | 2.350 |
Why?
| | Veterans | 6 | 2021 | 81 | 2.250 |
Why?
| | Forests | 11 | 2022 | 11 | 1.950 |
Why?
| | Oxygen Consumption | 11 | 2021 | 65 | 1.750 |
Why?
| | Heart Failure | 6 | 2017 | 232 | 1.730 |
Why?
| | Humans | 98 | 2022 | 31481 | 1.510 |
Why?
| | Exercise Tolerance | 8 | 2021 | 29 | 1.500 |
Why?
| | Quality of Life | 4 | 2021 | 663 | 1.410 |
Why?
| | Retrospective Studies | 39 | 2021 | 3591 | 1.400 |
Why?
| | Clinical Clerkship | 5 | 2015 | 29 | 1.390 |
Why?
| | Seeds | 5 | 2022 | 6 | 1.370 |
Why?
| | Male | 71 | 2021 | 17583 | 1.360 |
Why?
| | Pinus | 4 | 2018 | 4 | 1.320 |
Why?
| | Postoperative Complications | 18 | 2017 | 1083 | 1.310 |
Why?
| | Female | 69 | 2021 | 18253 | 1.290 |
Why?
| | Middle Aged | 59 | 2021 | 11209 | 1.280 |
Why?
| | Aged | 49 | 2021 | 10295 | 1.260 |
Why?
| | Cardiovascular Diseases | 6 | 2020 | 410 | 1.250 |
Why?
| | Educational Measurement | 4 | 2015 | 66 | 1.240 |
Why?
| | Image-Guided Biopsy | 2 | 2018 | 31 | 1.230 |
Why?
| | Internship and Residency | 5 | 2020 | 201 | 1.190 |
Why?
| | Adult | 45 | 2021 | 9779 | 1.180 |
Why?
| | Risk Factors | 26 | 2022 | 2664 | 1.160 |
Why?
| | Stomach Neoplasms | 3 | 2017 | 40 | 1.080 |
Why?
| | United States | 20 | 2022 | 2539 | 1.000 |
Why?
| | Students, Medical | 2 | 2013 | 46 | 0.990 |
Why?
| | Hypertension | 4 | 2021 | 283 | 0.970 |
Why?
| | Biomass | 3 | 2021 | 4 | 0.970 |
Why?
| | Weight Loss | 7 | 2014 | 114 | 0.960 |
Why?
| | Gastrointestinal Stromal Tumors | 2 | 2017 | 30 | 0.940 |
Why?
| | Predictive Value of Tests | 15 | 2019 | 637 | 0.930 |
Why?
| | Clinical Competence | 5 | 2020 | 274 | 0.900 |
Why?
| | Plant Dispersal | 3 | 2021 | 3 | 0.880 |
Why?
| | Herniorrhaphy | 7 | 2016 | 36 | 0.850 |
Why?
| | Climate Change | 5 | 2022 | 8 | 0.850 |
Why?
| | Risk Assessment | 15 | 2019 | 806 | 0.850 |
Why?
| | Surgeons | 1 | 2021 | 84 | 0.810 |
Why?
| | Birds | 1 | 2020 | 11 | 0.790 |
Why?
| | Hernia, Hiatal | 3 | 2014 | 14 | 0.790 |
Why?
| | Renal Dialysis | 1 | 2021 | 117 | 0.780 |
Why?
| | Societies, Medical | 1 | 2021 | 209 | 0.780 |
Why?
| | Plants | 3 | 2020 | 8 | 0.760 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 31 | 0.760 |
Why?
| | Treatment Outcome | 27 | 2017 | 3910 | 0.740 |
Why?
| | Hernia, Ventral | 4 | 2016 | 24 | 0.740 |
Why?
| | Follow-Up Studies | 18 | 2019 | 2028 | 0.740 |
Why?
| | Kidney Failure, Chronic | 1 | 2021 | 176 | 0.720 |
Why?
| | Patient Safety | 2 | 2016 | 53 | 0.720 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 99 | 0.720 |
Why?
| | Surgical Mesh | 4 | 2014 | 30 | 0.720 |
Why?
| | Bicycling | 1 | 2018 | 3 | 0.710 |
Why?
| | Surgical Procedures, Operative | 2 | 2019 | 40 | 0.690 |
Why?
| | Lymph Nodes | 2 | 2018 | 84 | 0.690 |
Why?
| | Muscle Contraction | 1 | 2018 | 84 | 0.680 |
Why?
| | Esophagogastric Junction | 1 | 2017 | 13 | 0.670 |
Why?
| | North America | 6 | 2022 | 44 | 0.640 |
Why?
| | Carcinoma, Renal Cell | 1 | 2017 | 46 | 0.640 |
Why?
| | Poaceae | 2 | 2018 | 5 | 0.630 |
Why?
| | Forecasting | 1 | 2017 | 134 | 0.630 |
Why?
| | Kidney Neoplasms | 1 | 2017 | 78 | 0.620 |
Why?
| | Biota | 3 | 2015 | 4 | 0.620 |
Why?
| | Physical Fitness | 4 | 2021 | 57 | 0.610 |
Why?
| | Cholecystectomy, Laparoscopic | 5 | 2015 | 39 | 0.610 |
Why?
| | Plant Development | 2 | 2020 | 3 | 0.590 |
Why?
| | Quality Indicators, Health Care | 1 | 2016 | 43 | 0.590 |
Why?
| | Altitude | 2 | 2015 | 3 | 0.590 |
Why?
| | Databases, Factual | 10 | 2021 | 391 | 0.590 |
Why?
| | Writing | 1 | 2015 | 22 | 0.580 |
Why?
| | Hospitals | 1 | 2016 | 142 | 0.570 |
Why?
| | Fires | 2 | 2012 | 3 | 0.560 |
Why?
| | Population Dynamics | 6 | 2016 | 11 | 0.560 |
Why?
| | Continuity of Patient Care | 1 | 2015 | 30 | 0.560 |
Why?
| | Abdominal Neoplasms | 1 | 2014 | 13 | 0.550 |
Why?
| | Quality Improvement | 6 | 2021 | 173 | 0.550 |
Why?
| | African Americans | 1 | 2022 | 818 | 0.550 |
Why?
| | Carbon Dioxide | 2 | 2017 | 21 | 0.540 |
Why?
| | Insurance, Health | 1 | 2014 | 27 | 0.540 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 385 | 0.540 |
Why?
| | Lymphoma | 1 | 2014 | 56 | 0.540 |
Why?
| | Radiography, Abdominal | 1 | 2014 | 7 | 0.530 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 226 | 0.520 |
Why?
| | Aptitude Tests | 1 | 2013 | 3 | 0.510 |
Why?
| | Specialties, Surgical | 1 | 2013 | 6 | 0.510 |
Why?
| | Animals, Laboratory | 1 | 2013 | 3 | 0.510 |
Why?
| | Education, Medical, Undergraduate | 1 | 2013 | 37 | 0.500 |
Why?
| | Pulmonary Ventilation | 2 | 2012 | 8 | 0.500 |
Why?
| | Education, Medical | 1 | 2013 | 45 | 0.490 |
Why?
| | Population Density | 4 | 2018 | 7 | 0.470 |
Why?
| | Proportional Hazards Models | 6 | 2017 | 390 | 0.470 |
Why?
| | Environment | 2 | 2012 | 56 | 0.460 |
Why?
| | Prospective Studies | 9 | 2019 | 1934 | 0.460 |
Why?
| | Logistic Models | 10 | 2016 | 479 | 0.460 |
Why?
| | Smoking | 4 | 2017 | 202 | 0.450 |
Why?
| | Ecology | 3 | 2018 | 6 | 0.450 |
Why?
| | Fertility | 5 | 2022 | 19 | 0.450 |
Why?
| | Reproducibility of Results | 4 | 2018 | 886 | 0.450 |
Why?
| | Motor Activity | 1 | 2014 | 397 | 0.430 |
Why?
| | Operative Time | 6 | 2019 | 97 | 0.430 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2011 | 13 | 0.420 |
Why?
| | Colectomy | 3 | 2016 | 33 | 0.420 |
Why?
| | Hemodynamics | 1 | 2011 | 103 | 0.410 |
Why?
| | Fluoroscopy | 2 | 2010 | 54 | 0.410 |
Why?
| | Survival Rate | 8 | 2017 | 465 | 0.410 |
Why?
| | Pilot Projects | 5 | 2019 | 455 | 0.400 |
Why?
| | Endosonography | 2 | 2007 | 15 | 0.400 |
Why?
| | Radiography, Interventional | 1 | 2010 | 29 | 0.400 |
Why?
| | Cholelithiasis | 1 | 2009 | 8 | 0.390 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2009 | 7 | 0.390 |
Why?
| | Gastric Outlet Obstruction | 1 | 2009 | 3 | 0.390 |
Why?
| | Heart Rate | 3 | 2019 | 161 | 0.390 |
Why?
| | Gastrectomy | 3 | 2017 | 26 | 0.390 |
Why?
| | Geography | 4 | 2022 | 22 | 0.390 |
Why?
| | Tropical Climate | 4 | 2021 | 4 | 0.380 |
Why?
| | Mycorrhizae | 2 | 2021 | 2 | 0.370 |
Why?
| | Prognosis | 10 | 2019 | 1028 | 0.370 |
Why?
| | Aged, 80 and over | 12 | 2021 | 5234 | 0.370 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2019 | 8 | 0.370 |
Why?
| | Soil | 3 | 2022 | 4 | 0.360 |
Why?
| | Conservation of Natural Resources | 2 | 2021 | 4 | 0.360 |
Why?
| | Anastomotic Leak | 2 | 2019 | 9 | 0.350 |
Why?
| | Formaldehyde | 2 | 1998 | 14 | 0.340 |
Why?
| | Omentum | 1 | 2007 | 10 | 0.340 |
Why?
| | Climate | 4 | 2022 | 5 | 0.340 |
Why?
| | Animals | 10 | 2020 | 5312 | 0.340 |
Why?
| | Rectum | 2 | 1998 | 72 | 0.330 |
Why?
| | Biological Evolution | 2 | 2018 | 24 | 0.320 |
Why?
| | Age Factors | 5 | 2018 | 943 | 0.320 |
Why?
| | Missouri | 3 | 2018 | 27 | 0.320 |
Why?
| | Liposarcoma | 1 | 2006 | 16 | 0.310 |
Why?
| | Diffusion of Innovation | 1 | 2006 | 41 | 0.300 |
Why?
| | Comorbidity | 5 | 2016 | 562 | 0.300 |
Why?
| | Biopsy, Fine-Needle | 1 | 2006 | 54 | 0.300 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2006 | 40 | 0.300 |
Why?
| | Education, Medical, Graduate | 2 | 2020 | 83 | 0.300 |
Why?
| | Cholecystolithiasis | 1 | 2005 | 2 | 0.300 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 47 | 0.300 |
Why?
| | Exercise Therapy | 2 | 2017 | 116 | 0.290 |
Why?
| | Mouthwashes | 1 | 2005 | 6 | 0.290 |
Why?
| | Hospitalization | 2 | 2019 | 359 | 0.280 |
Why?
| | Gastroesophageal Reflux | 1 | 2005 | 35 | 0.280 |
Why?
| | Endoscopy | 2 | 2021 | 181 | 0.280 |
Why?
| | Multivariate Analysis | 7 | 2017 | 390 | 0.270 |
Why?
| | Pneumonia | 3 | 2016 | 74 | 0.270 |
Why?
| | Lung | 2 | 2018 | 171 | 0.270 |
Why?
| | Registries | 4 | 2021 | 214 | 0.270 |
Why?
| | Pancreatic Neoplasms | 1 | 2006 | 181 | 0.270 |
Why?
| | Deer | 1 | 2004 | 2 | 0.260 |
Why?
| | Soil Microbiology | 2 | 2021 | 3 | 0.260 |
Why?
| | Time Factors | 10 | 2019 | 1902 | 0.260 |
Why?
| | Health Policy | 2 | 2021 | 52 | 0.260 |
Why?
| | Cause of Death | 2 | 2017 | 78 | 0.240 |
Why?
| | Movement | 1 | 2004 | 167 | 0.240 |
Why?
| | Abdominal Muscles | 1 | 2002 | 8 | 0.240 |
Why?
| | Laparotomy | 1 | 2002 | 25 | 0.240 |
Why?
| | Curriculum | 2 | 2020 | 158 | 0.240 |
Why?
| | Heart Diseases | 2 | 2016 | 102 | 0.230 |
Why?
| | Species Specificity | 4 | 2016 | 78 | 0.220 |
Why?
| | Chi-Square Distribution | 5 | 2013 | 178 | 0.220 |
Why?
| | Body Mass Index | 4 | 2012 | 458 | 0.220 |
Why?
| | Blood Transfusion | 3 | 2019 | 68 | 0.220 |
Why?
| | Obesity | 2 | 2022 | 338 | 0.220 |
Why?
| | Regeneration | 1 | 2021 | 30 | 0.220 |
Why?
| | Carbon Sequestration | 1 | 2021 | 1 | 0.220 |
Why?
| | Carbon | 1 | 2021 | 8 | 0.220 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2015 | 81 | 0.220 |
Why?
| | Forced Expiratory Volume | 1 | 2021 | 13 | 0.220 |
Why?
| | Adolescent | 6 | 2019 | 2667 | 0.210 |
Why?
| | Computer Simulation | 2 | 2020 | 249 | 0.210 |
Why?
| | Propofol | 1 | 2021 | 18 | 0.210 |
Why?
| | Information Dissemination | 1 | 2021 | 21 | 0.210 |
Why?
| | Respiratory Function Tests | 2 | 2012 | 36 | 0.210 |
Why?
| | Decompression, Surgical | 1 | 2002 | 146 | 0.210 |
Why?
| | Chest Pain | 2 | 2018 | 23 | 0.210 |
Why?
| | Delirium | 1 | 2021 | 41 | 0.210 |
Why?
| | Health Education | 1 | 2021 | 50 | 0.210 |
Why?
| | Health Care Costs | 1 | 2021 | 81 | 0.200 |
Why?
| | Electrocardiography | 3 | 2013 | 209 | 0.200 |
Why?
| | Wood | 1 | 2019 | 1 | 0.200 |
Why?
| | Anastomosis, Surgical | 2 | 2017 | 56 | 0.200 |
Why?
| | Biomedical Research | 1 | 2021 | 89 | 0.200 |
Why?
| | Carcinoma | 2 | 2016 | 84 | 0.190 |
Why?
| | Health Status | 2 | 2018 | 249 | 0.190 |
Why?
| | Hernia, Inguinal | 2 | 2016 | 23 | 0.190 |
Why?
| | Microbiota | 1 | 2020 | 94 | 0.190 |
Why?
| | Intraoperative Care | 2 | 2019 | 58 | 0.190 |
Why?
| | Severity of Illness Index | 2 | 2017 | 1240 | 0.190 |
Why?
| | Intestinal Diseases | 1 | 2019 | 11 | 0.180 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 27 | 0.180 |
Why?
| | Ixodidae | 1 | 2018 | 1 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 3 | 2016 | 230 | 0.180 |
Why?
| | Colonic Neoplasms | 2 | 2016 | 84 | 0.180 |
Why?
| | Spirometry | 1 | 2018 | 11 | 0.180 |
Why?
| | Diaphragm | 1 | 2018 | 7 | 0.170 |
Why?
| | Patient Satisfaction | 3 | 2013 | 315 | 0.170 |
Why?
| | Infant | 2 | 2019 | 642 | 0.170 |
Why?
| | Foreign-Body Migration | 1 | 2018 | 19 | 0.170 |
Why?
| | Atrial Fibrillation | 2 | 2013 | 197 | 0.170 |
Why?
| | Child, Preschool | 2 | 2019 | 786 | 0.170 |
Why?
| | Young Adult | 4 | 2021 | 2277 | 0.170 |
Why?
| | Southwestern United States | 1 | 2017 | 1 | 0.170 |
Why?
| | Northwestern United States | 1 | 2017 | 3 | 0.170 |
Why?
| | Antibiosis | 1 | 2017 | 2 | 0.170 |
Why?
| | Physical Therapists | 1 | 2017 | 4 | 0.170 |
Why?
| | Scoliosis | 1 | 2018 | 35 | 0.170 |
Why?
| | Nephrectomy | 1 | 2017 | 44 | 0.160 |
Why?
| | Geriatric Assessment | 1 | 2019 | 232 | 0.160 |
Why?
| | Urinary Retention | 1 | 2017 | 12 | 0.160 |
Why?
| | Surgical Stapling | 1 | 2017 | 9 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2018 | 281 | 0.160 |
Why?
| | Infant, Newborn | 1 | 2019 | 754 | 0.160 |
Why?
| | Europe | 1 | 2017 | 88 | 0.160 |
Why?
| | Bolivia | 2 | 2015 | 3 | 0.160 |
Why?
| | Alcoholism | 1 | 2017 | 90 | 0.160 |
Why?
| | Child | 3 | 2019 | 1572 | 0.150 |
Why?
| | California | 3 | 2013 | 35 | 0.150 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.150 |
Why?
| | Enterostomy | 1 | 2016 | 6 | 0.150 |
Why?
| | Secondary Prevention | 1 | 2016 | 67 | 0.150 |
Why?
| | Observer Variation | 1 | 2016 | 146 | 0.150 |
Why?
| | Pollination | 1 | 2015 | 1 | 0.150 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 115 | 0.150 |
Why?
| | Stroke Volume | 2 | 2013 | 64 | 0.150 |
Why?
| | Ventricular Function, Left | 2 | 2013 | 63 | 0.150 |
Why?
| | Cohort Studies | 4 | 2015 | 2014 | 0.150 |
Why?
| | Fundoplication | 2 | 2013 | 24 | 0.140 |
Why?
| | End Stage Liver Disease | 1 | 2015 | 17 | 0.140 |
Why?
| | Plant Physiological Phenomena | 1 | 2015 | 1 | 0.140 |
Why?
| | Surgical Instruments | 2 | 2007 | 30 | 0.140 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 159 | 0.140 |
Why?
| | Job Application | 1 | 2015 | 8 | 0.140 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 467 | 0.140 |
Why?
| | Certification | 1 | 2015 | 60 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2016 | 158 | 0.140 |
Why?
| | Gastroscopy | 1 | 2015 | 10 | 0.140 |
Why?
| | Gallbladder Neoplasms | 1 | 2015 | 6 | 0.140 |
Why?
| | Gastrostomy | 1 | 2015 | 12 | 0.140 |
Why?
| | Appendectomy | 1 | 2014 | 13 | 0.140 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 300 | 0.140 |
Why?
| | Appendicitis | 1 | 2014 | 14 | 0.140 |
Why?
| | Environmental Monitoring | 1 | 2014 | 8 | 0.140 |
Why?
| | Diabetes Mellitus | 3 | 2017 | 150 | 0.140 |
Why?
| | Medical History Taking | 1 | 2014 | 26 | 0.140 |
Why?
| | Length of Stay | 5 | 2018 | 377 | 0.140 |
Why?
| | Patient Readmission | 1 | 2016 | 129 | 0.140 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 82 | 0.140 |
Why?
| | Quality of Health Care | 1 | 2016 | 141 | 0.140 |
Why?
| | Cardiovascular Agents | 1 | 2014 | 34 | 0.140 |
Why?
| | Program Evaluation | 2 | 2013 | 153 | 0.130 |
Why?
| | Occupational Health | 1 | 2014 | 27 | 0.130 |
Why?
| | Blood Pressure | 3 | 2012 | 260 | 0.130 |
Why?
| | Analysis of Variance | 3 | 2012 | 364 | 0.130 |
Why?
| | Incidence | 1 | 2017 | 829 | 0.130 |
Why?
| | Credentialing | 1 | 2014 | 9 | 0.130 |
Why?
| | Biliary Dyskinesia | 1 | 2013 | 4 | 0.130 |
Why?
| | Odds Ratio | 5 | 2015 | 327 | 0.130 |
Why?
| | Activities of Daily Living | 1 | 2017 | 495 | 0.130 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2013 | 13 | 0.130 |
Why?
| | Intestine, Small | 1 | 2014 | 37 | 0.130 |
Why?
| | Preoperative Period | 1 | 2014 | 73 | 0.130 |
Why?
| | Rest | 1 | 2013 | 33 | 0.130 |
Why?
| | Prosthesis Failure | 1 | 2018 | 534 | 0.130 |
Why?
| | Walking | 1 | 2016 | 249 | 0.130 |
Why?
| | Gallbladder Diseases | 1 | 2013 | 6 | 0.130 |
Why?
| | Elective Surgical Procedures | 1 | 2014 | 55 | 0.130 |
Why?
| | ROC Curve | 1 | 2013 | 153 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2015 | 137 | 0.130 |
Why?
| | Cholecystectomy | 1 | 2013 | 19 | 0.120 |
Why?
| | Abdominal Wall | 1 | 2013 | 4 | 0.120 |
Why?
| | Quercus | 1 | 2012 | 1 | 0.120 |
Why?
| | Carya | 1 | 2012 | 1 | 0.120 |
Why?
| | Disease Progression | 2 | 2018 | 861 | 0.120 |
Why?
| | Disease-Free Survival | 1 | 2013 | 241 | 0.120 |
Why?
| | Louisiana | 1 | 2012 | 1 | 0.110 |
Why?
| | Flowers | 1 | 2012 | 1 | 0.110 |
Why?
| | Health Promotion | 1 | 2014 | 186 | 0.110 |
Why?
| | Sepsis | 1 | 2014 | 157 | 0.110 |
Why?
| | Foreign Bodies | 1 | 1992 | 25 | 0.110 |
Why?
| | Physicians | 1 | 2014 | 120 | 0.110 |
Why?
| | Anxiety | 1 | 2013 | 162 | 0.110 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 22 | 0.110 |
Why?
| | Postoperative Care | 1 | 2012 | 141 | 0.110 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 580 | 0.110 |
Why?
| | Ileal Neoplasms | 1 | 2011 | 3 | 0.110 |
Why?
| | Recreation | 1 | 2011 | 3 | 0.110 |
Why?
| | Esophagus | 1 | 2012 | 60 | 0.110 |
Why?
| | Spinal Fusion | 1 | 2018 | 464 | 0.110 |
Why?
| | Peripheral Arterial Disease | 1 | 2011 | 21 | 0.110 |
Why?
| | Water | 1 | 2011 | 37 | 0.110 |
Why?
| | Reference Standards | 2 | 2021 | 38 | 0.110 |
Why?
| | Illinois | 2 | 2014 | 266 | 0.100 |
Why?
| | Phylogeny | 2 | 2021 | 67 | 0.100 |
Why?
| | Reoperation | 3 | 2016 | 938 | 0.100 |
Why?
| | Demography | 1 | 2011 | 83 | 0.100 |
Why?
| | Melanoma | 1 | 2011 | 63 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2013 | 281 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2011 | 85 | 0.100 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2010 | 1 | 0.100 |
Why?
| | Methylene Blue | 1 | 2010 | 4 | 0.100 |
Why?
| | Coronary Circulation | 1 | 2010 | 49 | 0.100 |
Why?
| | Duodenostomy | 1 | 2009 | 2 | 0.100 |
Why?
| | Jejunostomy | 1 | 2009 | 8 | 0.100 |
Why?
| | Heart | 1 | 2010 | 110 | 0.090 |
Why?
| | Conscious Sedation | 1 | 2009 | 6 | 0.090 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 84 | 0.090 |
Why?
| | Safety | 1 | 2009 | 59 | 0.090 |
Why?
| | Neutropenia | 1 | 2008 | 26 | 0.090 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2010 | 63 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2009 | 42 | 0.090 |
Why?
| | Stomach Diseases | 1 | 2008 | 2 | 0.090 |
Why?
| | Pancreatic Cyst | 1 | 2008 | 5 | 0.090 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2008 | 44 | 0.090 |
Why?
| | Administration, Rectal | 2 | 1998 | 6 | 0.090 |
Why?
| | Models, Theoretical | 2 | 2021 | 112 | 0.090 |
Why?
| | Reproduction | 2 | 2022 | 11 | 0.080 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 10 | 0.080 |
Why?
| | Bile Ducts | 1 | 2007 | 14 | 0.080 |
Why?
| | Ischemia | 1 | 2007 | 35 | 0.080 |
Why?
| | Temperature | 2 | 2022 | 85 | 0.080 |
Why?
| | Dogs | 2 | 1998 | 283 | 0.080 |
Why?
| | Survival Analysis | 4 | 2015 | 379 | 0.080 |
Why?
| | Splenectomy | 1 | 2006 | 8 | 0.080 |
Why?
| | Stomach | 1 | 2006 | 19 | 0.080 |
Why?
| | Pancreatectomy | 1 | 2006 | 18 | 0.080 |
Why?
| | Pancreas | 1 | 2006 | 36 | 0.080 |
Why?
| | Prostaglandins F, Synthetic | 1 | 2005 | 2 | 0.070 |
Why?
| | Glaucoma | 1 | 2005 | 5 | 0.070 |
Why?
| | Intraocular Pressure | 1 | 2005 | 8 | 0.070 |
Why?
| | Sleep Apnea Syndromes | 1 | 2006 | 36 | 0.070 |
Why?
| | Intestines | 2 | 2017 | 114 | 0.070 |
Why?
| | Intestinal Mucosa | 2 | 1998 | 235 | 0.070 |
Why?
| | Neoplasms | 1 | 2008 | 280 | 0.070 |
Why?
| | Confidence Intervals | 2 | 2015 | 102 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2005 | 91 | 0.070 |
Why?
| | Plants, Edible | 1 | 2004 | 2 | 0.070 |
Why?
| | Territoriality | 1 | 2004 | 2 | 0.070 |
Why?
| | Surgical Wound Infection | 2 | 2016 | 106 | 0.060 |
Why?
| | Prostheses and Implants | 1 | 2005 | 166 | 0.060 |
Why?
| | Compartment Syndromes | 1 | 2002 | 10 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2004 | 122 | 0.060 |
Why?
| | Recurrence | 2 | 2014 | 389 | 0.060 |
Why?
| | Microclimate | 1 | 2022 | 1 | 0.060 |
Why?
| | Uncertainty | 1 | 2022 | 7 | 0.060 |
Why?
| | Sex Factors | 2 | 2016 | 542 | 0.060 |
Why?
| | Military Personnel | 1 | 2002 | 46 | 0.060 |
Why?
| | Recovery of Function | 2 | 2016 | 309 | 0.060 |
Why?
| | South America | 1 | 2021 | 5 | 0.050 |
Why?
| | Angina Pectoris | 2 | 2016 | 18 | 0.050 |
Why?
| | Anesthesia, Intravenous | 1 | 2021 | 6 | 0.050 |
Why?
| | Organizational Policy | 1 | 2021 | 16 | 0.050 |
Why?
| | Reference Values | 1 | 2021 | 260 | 0.050 |
Why?
| | Respiratory Tract Diseases | 1 | 2021 | 8 | 0.050 |
Why?
| | Rehabilitation | 1 | 2021 | 15 | 0.050 |
Why?
| | Seasons | 1 | 2021 | 36 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2021 | 33 | 0.050 |
Why?
| | Plant Roots | 1 | 2020 | 1 | 0.050 |
Why?
| | Rhizosphere | 1 | 2020 | 1 | 0.050 |
Why?
| | Endophytes | 1 | 2020 | 1 | 0.050 |
Why?
| | Grassland | 1 | 2020 | 1 | 0.050 |
Why?
| | Risk Reduction Behavior | 1 | 2021 | 59 | 0.050 |
Why?
| | Smoking Cessation | 1 | 2021 | 53 | 0.050 |
Why?
| | Transforming Growth Factor alpha | 1 | 2000 | 7 | 0.050 |
Why?
| | Lymphokines | 1 | 2000 | 13 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2000 | 8 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 52 | 0.050 |
Why?
| | Electroencephalography | 1 | 2021 | 145 | 0.050 |
Why?
| | Carbon Cycle | 1 | 2019 | 1 | 0.050 |
Why?
| | Bacteria | 1 | 2020 | 74 | 0.050 |
Why?
| | Isoxazoles | 1 | 1999 | 17 | 0.050 |
Why?
| | Oximetry | 1 | 2019 | 14 | 0.050 |
Why?
| | International Cooperation | 1 | 2019 | 38 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 1999 | 29 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 891 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2019 | 50 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2000 | 68 | 0.050 |
Why?
| | Esophageal Neoplasms | 1 | 2000 | 61 | 0.050 |
Why?
| | Patient Education as Topic | 1 | 2021 | 192 | 0.050 |
Why?
| | Telemedicine | 1 | 2021 | 99 | 0.050 |
Why?
| | Evidence-Based Practice | 1 | 2019 | 86 | 0.050 |
Why?
| | Nymph | 1 | 2018 | 1 | 0.040 |
Why?
| | Larva | 1 | 2018 | 3 | 0.040 |
Why?
| | Chronic Disease | 1 | 2021 | 544 | 0.040 |
Why?
| | Hemoptysis | 1 | 2018 | 9 | 0.040 |
Why?
| | Proctitis | 1 | 1998 | 3 | 0.040 |
Why?
| | Compliance | 1 | 1998 | 8 | 0.040 |
Why?
| | Southeastern United States | 1 | 2018 | 15 | 0.040 |
Why?
| | Manometry | 1 | 1998 | 28 | 0.040 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 39 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 1998 | 29 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 224 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2013 | 687 | 0.040 |
Why?
| | Collagen | 1 | 1998 | 111 | 0.040 |
Why?
| | Lymph Node Excision | 2 | 2015 | 37 | 0.040 |
Why?
| | Radiation Injuries | 1 | 1998 | 44 | 0.040 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1976 | 8 | 0.040 |
Why?
| | Kinetics | 1 | 2017 | 278 | 0.040 |
Why?
| | Peripheral Vascular Diseases | 1 | 2016 | 15 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 1999 | 274 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2017 | 106 | 0.040 |
Why?
| | Satellite Imagery | 1 | 2016 | 1 | 0.040 |
Why?
| | Remote Sensing Technology | 1 | 2016 | 3 | 0.040 |
Why?
| | Equipment Design | 1 | 2017 | 198 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 42 | 0.040 |
Why?
| | Cholangiography | 1 | 2015 | 12 | 0.040 |
Why?
| | Hernia, Umbilical | 1 | 2015 | 4 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2016 | 90 | 0.040 |
Why?
| | Prevalence | 2 | 2011 | 544 | 0.040 |
Why?
| | Spatial Analysis | 1 | 2015 | 1 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 2015 | 9 | 0.040 |
Why?
| | Ultrasonography, Interventional | 1 | 2015 | 73 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 71 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 75 | 0.030 |
Why?
| | Workplace | 1 | 2014 | 26 | 0.030 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2014 | 26 | 0.030 |
Why?
| | Hepatectomy | 1 | 2015 | 65 | 0.030 |
Why?
| | Regression Analysis | 1 | 2015 | 319 | 0.030 |
Why?
| | Colonic Diseases | 1 | 2014 | 17 | 0.030 |
Why?
| | Breath Tests | 1 | 2013 | 10 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 181 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2013 | 34 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 1997 | 832 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2014 | 66 | 0.030 |
Why?
| | Prosthesis Implantation | 1 | 2013 | 43 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2015 | 192 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2014 | 99 | 0.030 |
Why?
| | Wound Healing | 1 | 2014 | 175 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2015 | 481 | 0.030 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2013 | 101 | 0.030 |
Why?
| | Disease Management | 1 | 2014 | 147 | 0.030 |
Why?
| | Phylogeography | 1 | 2012 | 1 | 0.030 |
Why?
| | Italy | 1 | 2012 | 16 | 0.030 |
Why?
| | Systole | 1 | 2012 | 22 | 0.030 |
Why?
| | Retroperitoneal Space | 1 | 1992 | 14 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2012 | 50 | 0.030 |
Why?
| | Heart-Assist Devices | 1 | 2012 | 31 | 0.030 |
Why?
| | Anticoagulants | 1 | 2013 | 151 | 0.030 |
Why?
| | Laparoscopes | 1 | 2011 | 3 | 0.030 |
Why?
| | Ankle Brachial Index | 1 | 2011 | 7 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 1991 | 18 | 0.030 |
Why?
| | Prostatectomy | 1 | 1991 | 23 | 0.030 |
Why?
| | Triglycerides | 1 | 2011 | 50 | 0.030 |
Why?
| | Hot Temperature | 1 | 2010 | 26 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2011 | 117 | 0.030 |
Why?
| | Hemorrhage | 1 | 1991 | 90 | 0.030 |
Why?
| | BCG Vaccine | 1 | 1990 | 2 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 1991 | 76 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1990 | 11 | 0.030 |
Why?
| | Vascular Surgical Procedures | 1 | 2011 | 56 | 0.030 |
Why?
| | Switzerland | 1 | 2010 | 9 | 0.030 |
Why?
| | Carcinoma, Transitional Cell | 1 | 1990 | 17 | 0.030 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1990 | 34 | 0.030 |
Why?
| | Blood Glucose | 1 | 2011 | 137 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2010 | 45 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 494 | 0.020 |
Why?
| | Education, Professional | 1 | 2009 | 8 | 0.020 |
Why?
| | Equipment and Supplies | 1 | 2009 | 16 | 0.020 |
Why?
| | Documentation | 1 | 2009 | 27 | 0.020 |
Why?
| | Pharmaceutical Preparations | 1 | 2009 | 24 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1990 | 236 | 0.020 |
Why?
| | Quality Assurance, Health Care | 1 | 2009 | 54 | 0.020 |
Why?
| | Teaching | 1 | 2009 | 68 | 0.020 |
Why?
| | Mortality | 1 | 2009 | 99 | 0.020 |
Why?
| | Cysts | 1 | 2008 | 21 | 0.020 |
Why?
| | Community-Acquired Infections | 1 | 2008 | 77 | 0.020 |
Why?
| | Emergencies | 1 | 2008 | 41 | 0.020 |
Why?
| | Device Removal | 1 | 2008 | 101 | 0.020 |
Why?
| | Monitoring, Intraoperative | 1 | 2007 | 43 | 0.020 |
Why?
| | Patient Selection | 1 | 2009 | 264 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2010 | 986 | 0.020 |
Why?
| | Patient Participation | 1 | 2005 | 52 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2005 | 378 | 0.020 |
Why?
| | Aerospace Medicine | 1 | 2002 | 4 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 2002 | 39 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2000 | 10 | 0.010 |
Why?
| | von Willebrand Factor | 1 | 2000 | 11 | 0.010 |
Why?
| | Barrett Esophagus | 1 | 2000 | 19 | 0.010 |
Why?
| | Esophagectomy | 1 | 2000 | 25 | 0.010 |
Why?
| | Pyrimidine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 1 | 0.010 |
Why?
| | Receptors, Growth Factor | 1 | 1999 | 3 | 0.010 |
Why?
| | Crotonates | 1 | 1999 | 4 | 0.010 |
Why?
| | Toluidines | 1 | 1999 | 4 | 0.010 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 1999 | 13 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1999 | 24 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1999 | 19 | 0.010 |
Why?
| | Mice, Nude | 1 | 1999 | 39 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2000 | 70 | 0.010 |
Why?
| | Tyrosine | 1 | 1999 | 28 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2000 | 156 | 0.010 |
Why?
| | Nitriles | 1 | 1999 | 17 | 0.010 |
Why?
| | Hydroxybutyrates | 1 | 1999 | 7 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1999 | 40 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2000 | 107 | 0.010 |
Why?
| | Cell Division | 1 | 1999 | 122 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 155 | 0.010 |
Why?
| | Glioma | 1 | 1999 | 58 | 0.010 |
Why?
| | ErbB Receptors | 1 | 1999 | 78 | 0.010 |
Why?
| | Phosphorylation | 1 | 1999 | 199 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1999 | 296 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 1999 | 163 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1999 | 207 | 0.010 |
Why?
| | History of Medicine | 1 | 1976 | 1 | 0.010 |
Why?
| | Tuberculosis, Bovine | 1 | 1976 | 1 | 0.010 |
Why?
| | Hospitals, Special | 1 | 1976 | 6 | 0.010 |
Why?
| | Cattle | 1 | 1976 | 260 | 0.010 |
Why?
| | Mice | 1 | 1999 | 1894 | 0.010 |
Why?
| | Hematocrit | 1 | 1991 | 15 | 0.010 |
Why?
| | Pelvis | 1 | 1991 | 26 | 0.010 |
Why?
| | Administration, Intravesical | 1 | 1990 | 4 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 1991 | 122 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 1990 | 257 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 1991 | 237 | 0.010 |
Why?
|
|
Myers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|